• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性息肉样脉络膜血管病变(IPCV)。1990 年。

Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990.

出版信息

Retina. 2012 Feb;32 Suppl 1:1-8.

PMID:22451948
Abstract

Eleven patients, 40 to 71 years old, had a choroidal vasculopathy that led to hemorrhagic and exudative macular degeneration. The patients had peculiar polypoidal, subretinal, vascular lesions associated with serous and hemorrhagic detachments of the retinal pigment epithelium. This macular disorder, which we have named idiopathic polypoidal choroidal vasculopathy (IPCV), appears to represent a distinct entity that differs clinically and demograph-ically from age-related macular degeneration (AMD) and other macular diseases associated with subretinal neovascularization. Recognition of this condition is important because it may have specific risk factors, natural course, and management considerations that differ from those of age-related macular degeneration

摘要

11 名 40 至 71 岁的患者患有脉络膜血管病变,导致出血性和渗出性黄斑变性。这些患者具有独特的息肉样、视网膜下、血管病变,伴有视网膜色素上皮的浆液性和出血性脱离。我们将这种黄斑疾病命名为特发性息肉样脉络膜血管病变(IPCV),它似乎代表一种与年龄相关性黄斑变性(AMD)和其他与视网膜下新生血管有关的黄斑疾病在临床上和人口统计学上不同的独特实体。认识到这种情况很重要,因为它可能具有与年龄相关性黄斑变性不同的特定风险因素、自然病程和管理注意事项。

相似文献

1
Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990.特发性息肉样脉络膜血管病变(IPCV)。1990 年。
Retina. 2012 Feb;32 Suppl 1:1-8.
2
Idiopathic polypoidal choroidal vasculopathy (IPCV).特发性息肉样脉络膜血管病变(IPCV)。
Retina. 1990;10(1):1-8.
3
Polypoidal choroidal vasculopathy.息肉样脉络膜血管病变
Surv Ophthalmol. 2004 Jan-Feb;49(1):25-37. doi: 10.1016/j.survophthal.2003.10.007.
4
Idiopathic polypoidal choroidal vasculopathy (IPCV) presenting with simultaneous choroidal neovascular membrane (CNM).
Optom Vis Sci. 2004 Jul;81(7):491-8. doi: 10.1097/00006324-200407000-00009.
5
Idiopathic polypoidal choroidal vasculopathy.
Vojnosanit Pregl. 2012 Jan;69(1):85-9.
6
Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy.特发性息肉样脉络膜血管病变患者眼中橙红色视网膜下病变的光学相干断层扫描
Am J Ophthalmol. 2000 Jan;129(1):21-6. doi: 10.1016/s0002-9394(99)00253-6.
7
Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.特发性息肉状脉络膜血管病变的吲哚菁绿视频血管造影
Retina. 1995;15(2):100-10. doi: 10.1097/00006982-199515020-00003.
8
Idiopathic polypoidal choroidal vasculopathy of the macula.特发性黄斑息肉样脉络膜血管病变
Ophthalmology. 1998 Aug;105(8):1380-5. doi: 10.1016/S0161-6420(98)98016-2.
9
[Idiopathic polypoidal choroidal vasculopathy: its extreme aspects in one patient--case report].
Arq Bras Oftalmol. 2005 Mar-Apr;68(2):253-6. doi: 10.1590/s0004-27492005000200019. Epub 2005 May 18.
10
Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.比较健康眼、早期年龄相关性黄斑病变、新生血管性年龄相关性黄斑变性、中心性浆液性脉络膜视网膜病变和息肉样脉络膜血管病变患者的脉络膜厚度。
Retina. 2011 Oct;31(9):1904-11. doi: 10.1097/IAE.0b013e31821801c5.

引用本文的文献

1
Imaging-Guided Classification of Neovascularization in Neovascular Age-Related Macular Degeneration: Progress to Date.影像引导下新生血管性年龄相关性黄斑变性新生血管的分类:迄今进展
J Vitreoretin Dis. 2024 Oct 5:24741264241276929. doi: 10.1177/24741264241276929.
2
INCIDENCE AND PROGRESSION OF AGE-RELATED MACULAR DEGENERATION AMONG PATIENTS WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEA: A National Cohort Study.患有和未患有阻塞性睡眠呼吸暂停的患者中年龄相关性黄斑变性的发病率和进展:一项全国队列研究。
Retina. 2025 Feb 1;45(2):198-206. doi: 10.1097/IAE.0000000000004293.
3
Efficacy of Brolucizumab in Polyp Regression of Treatment-Naive Polypoidal Choroidal Vasculopathy and Its Effect on 1-Year Treatment Outcome.
布罗卢izumab在初治息肉样脉络膜血管病变息肉消退中的疗效及其对1年治疗结果的影响。
Korean J Ophthalmol. 2024 Jun;38(3):185-193. doi: 10.3341/kjo.2023.0145. Epub 2024 Apr 8.
4
Cost and Outcomes Analysis of Polypoidal Choroidal Vasculopathy (Aneurysmal Type 1 Neovascularization) Treatment Strategies.息肉样脉络膜血管病变(动脉瘤样1型新生血管)治疗策略的成本与疗效分析
J Vitreoretin Dis. 2020 Oct 16;5(3):227-231. doi: 10.1177/2474126420946599. eCollection 2021 May-Jun.
5
Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.息肉样脉络膜血管病变继发玻璃体积血突破的临床特征和转归。
PLoS One. 2022 Dec 30;17(12):e0279778. doi: 10.1371/journal.pone.0279778. eCollection 2022.
6
One year outcomes of eyes with polypoidal choroidal vasculopathy with ≥20/40 visual acuity treated with anti-vascular endothelial growth factor agents.接受抗血管内皮生长因子药物治疗的视力≥20/40的息肉状脉络膜血管病变患者的一年预后
Saudi J Ophthalmol. 2022 Feb 18;35(2):84-87. doi: 10.4103/1319-4534.337862. eCollection 2021 Apr-Jun.
7
One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study.质子束照射联合玻璃体内注射康柏西普治疗难治性或复发性息肉状脉络膜血管病变的一年疗效和安全性:一项前瞻性研究
Ophthalmol Ther. 2022 Feb;11(1):187-199. doi: 10.1007/s40123-021-00409-3. Epub 2021 Nov 13.
8
Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography.光学相干断层扫描血管造影下不同分支血管网络形态的息肉状脉络膜血管病变的临床特征和预后。
Sci Rep. 2021 Sep 8;11(1):17848. doi: 10.1038/s41598-021-97340-1.
9
Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.特发性息肉样脉络膜血管病变的超广角吲哚菁绿血管造影的脉络膜血管异常。
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):29. doi: 10.1167/iovs.62.2.29.
10
One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity.伴有良好视力的息肉样脉络膜血管病变的阿柏西普治疗一年的结果。
Korean J Ophthalmol. 2021 Feb;35(1):26-36. doi: 10.3341/kjo.2020.0096. Epub 2020 Dec 11.